Vita Coco
COCO · NASDAQ
About COCO
- Employees
- 336
- Headquarters
- New York City, New York
- Listed
- Oct 21, 2021
- Sector
- Consumer Staples
- Industry
- Beverages
- Website
- vitacoco.com
COCO key statistics
- Market cap
- 3.39B
- Price-earnings ratio
- 32.64
- Dividend yield
- —
- Average volume
- 1.10M
- Volume
- 1.07M
- Open price
- $59.91
- High today
- $62.21
- Low today
- $58.76
- 52 Week high
- $85.83
- 52 Week low
- $39.46
Vita Coco (COCO) at a glance
As of Oct 20, 2026, Vita Coco (COCO) shares are priced at $61.77, giving the company a market cap of 3.39B and a price-to-earnings ratio of 32.64.
Today the stock has traded between $58.76 and $62.21. The current price is 5.1% above the day's low and 0.7% below its high.
Volume so far is 1.07M shares, in line with the average of 1.10M shares a day.
Over the past year Vita Coco has ranged from $39.46 to $85.83, and now sits 48% of the way up that range.
Vita Coco met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.82 per share against an estimate of $0.5675.
The average analyst price target is $83.54, 35.2% above the current price, from 9 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy88.9%
- Hold11.1%
- Sell0.0%
- Low
- $68.68
- Now
- $61.77
- High
- $94.50
COCO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 33.8% on average.
- Q3 FY24: reported $0.32 per share against an estimate of $0.2665
- Q4 FY24: reported $0.06 per share against an estimate of $0.0638
- Q1 FY25: reported $0.31 per share against an estimate of $0.2048
- Q2 FY25: reported $0.38 per share against an estimate of $0.3697
- Q3 FY25: reported $0.40 per share against an estimate of $0.3057
- Q4 FY25: reported $0.09 per share against an estimate of $0.1259
- Q1 FY26: reported $0.50 per share against an estimate of $0.3258
- Q2 FY26: reported $0.82 per share against an estimate of $0.5675
COCO news
- Caroline Ryan
Deal Dispatch: Intersnack Group Buys Utz, Vita Coco Acquires Copra Coconuts, TGI Friday's Wins Chapter 11 Liquidation Plan
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
Vita Coco Reports Q1 2026 Results: Full Earnings Call Transcript
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of The Vita Coco Company, Inc. – COCO
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
- Press releaseBusiness Wire
COCO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving The Vita Coco Company, Inc.
Similar companies
Companies in the same industry as Vita Coco
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.